Syngene International Limited (NSE:SYNGENE)

Market Cap	286.41B
Revenue (ttm)	35.41B
Net Income (ttm)	5.02B
Shares Out	401.28M
EPS (ttm)	12.48
PE Ratio	57.17
Forward PE	47.87
Dividend	1.25 (0.18%)
Ex-Dividend Date	Jun 28, 2024

Volume	1,474,470
Average Volume	783,926
Open	717.45
Previous Close	714.60
Day's Range	704.60 - 726.00
52-Week Range	607.65 - 960.60
Beta	0.57
RSI	34.75
Earnings Date	Apr 24, 2025

About Syngene International

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, prot...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1993
• Employees: 6,510
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SYNGENE

Financial Performance

In 2023, Syngene International's revenue was 34.89 billion, an increase of 9.26% compared to the previous year's 31.93 billion. Earnings were 5.10 billion, an increase of 9.82%.